Cytomegalovirus infection trials in Italy

3 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A phase 2, multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipients with cytomegalovirus (CMV) infection with a medical condition that contraindicate the administration of ganciclovir, valganciclovir or foscarnet and in those who discontinued first line preemptive therapy with ganciclovir, valganciclovir or foscarnet due to toxicity or intolerance.

  Where

  Alexandria, Bergamo, Bologna, Brescia, Cagliari, Florence, Genoa, Milan, Monza, Naples, Palermo, Perugia, Reggio Calabria, Rome, San Giovanni Rotondo, Turin, Udine

  Age

  18 years and over

  People

  81

  Run by

  Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare

  See details and how to join2025-521074-34-00
• Phase 3Taking people
  Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

  Where

  Rome

  Age

  2 months and over

  People

  149 worldwide

  Run by

  Tobias Feuchtinger

  See details and how to joinNCT04832607 · EU 2024-512321-84-00
• Phase 1Taking people
  Linfociti T virus-specifici per infezioni virali resistenti alla terapia farmacologica dopo trapianto allogenico di cellule staminali emopoietiche e in pazienti con grave immunodepressione primitiva o secondaria

  Where

  Genoa

  Age

  Up to 64 years

  People

  10

  Run by

  IRCCS Istituto Giannina Gaslini

  See details and how to joinNCT05075837 · EU 2024-518925-14-02